Endocrine disease biotech Cortendo files for a $86 million IPO

usa ipo news

(Renaissance Capital)Cortendo, which is in-licensing and developing therapies for rare endocrine disorders, filed on Friday with the SEC to raise up to $86 million in an initial public offering.
Its stock currently trades on the Norwegian OTC market under the symbol CORT with a market cap of over $300 million.

The Trevose, PA-based company, which was founded in 1996, plans to list on the Nasdaq under the symbol SBBP. Cortendo initially filed confidentially on 6/12/2015. BofA Merrill Lynch and Stifel are the joint bookrunners on the deal. No pricing terms were disclosed.


new ipo news
Share on Google Plus

About Jessica Hornberger

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.
    Blogger Comment
    Facebook Comment